Skip to content
Disclosery

Remedium Capital Partners, LLC: CBIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Remedium Capital Partners, LLC on CBIO, newest first. How the timeline and the estimate are built.

Remedium Capital Partners, LLC held 361,250 CBIO shares at 2026-06-30 per its 13F-HR filed 2026-08-07.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 361,250 shares
    Change vs previous 13F not available

    1.44% of the 13F portfolio, value $6,502,500.

    13F-HR 0002104501-26-000015 filed by Remedium Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec ยง4.2).